First Status Conference — In Minnesota District Court — Come January 12, 2016

Kenilworth’s role will likely be slight, in this purported MDL, as it acts merely as a fluoroquinolone distributor, not a manufacturer, if I understand the fact pattern correctly, here. I think (if memory serves) Merck distributes for Bayer, under an old contract — and Avelox® is one of a wide class of fluoroquinolones on market, in the US. My backgrounder here — when this was transferred, from Chicago to Minneapolis — last September.

In any event, here is the new status hearing date — which promises to be a very chilly trip north in January, for anyone headed to the federal District Court in Minneapolis:

. . . .Initial Status Conference is now set for 1/12/2016 at 01:30 PM in Courtroom 15E (MPLS) before Chief Judge John R. Tunheim. . . .

Onward, and smoothly, so. . .

Advertisements

There are no comments on this post.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: